Form 4/A for HIMS Hims & Hers Health, Inc.
Accepted 2023-03-17 00:00:00 ET · period of report 2023-03-01 · accession 0001773751-23-000098 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2023-03-17 | 2023-03-01 | HIMS | Dudum Andrew | CEO, Dir, 10% | M - OptEx | $2.43 | +36.6K | 387.2K | +10% | +$89.0K |
| DA | 2023-03-17 | 2023-03-01 | HIMS | Dudum Andrew | CEO, Dir, 10% | S - Sale+OE | $11.95 | -36.6K | 350.6K | -9% | -$437.8K |
| DA | 2023-03-17 | 2023-03-01 | HIMS | Dudum Andrew | CEO, Dir, 10% | M - OptEx | $0.00 | -36.6K | 3.21M | -1% | $0 |
| DMA | 2023-03-17 | 2023-03-01 | HIMS | Dudum Andrew | CEO, Dir, 10% | A - Grant | $0.00 | +781.6K | 214.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-03-01 | M | A | 36,633 | $2.43 | 387,248 | D | — | — | (F1) The option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 3, 2022 by the Reporting Person. |
| 2 | Common | Class A Common Stock | 2023-03-01 | S | D | 36,633 | $11.95 | 350,615 | D | — | — | (F1) The option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 3, 2022 by the Reporting Person. (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.95 - $12.02. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (right to buy) | 2023-03-01 | M | D | 36,633 | $0.00 | 3,209,506 | D | $2.43 · — to 2030-06-16 | 36,633 Class A Common Stock | (F3) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. |
| 4 | Derivative | Restricted Stock Unit | 2023-03-01 | A | A | 567,144 | $0.00 | 567,144 | D | $0.00 · 2023-06-15 to — | 567,144 Class A Common Stock | (F4) The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. |
| 5 | Derivative | Stock Option (right to buy) | 2023-03-01 | A | A | 214,461 | $0.00 | 214,461 | D | $11.53 · — to 2033-03-01 | 214,461 Class A Common Stock | (F5) The exercise price of the options awarded has been adjusted from the original filing due to administrative error. (F6) The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023. |